Prospective, Multi-center Study to Assess Posterolateral Fusion Using FIBERGRAFT

NACompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

February 19, 2019

Primary Completion Date

May 21, 2023

Study Completion Date

May 21, 2023

Conditions
Degenerative Disc DiseaseSpondylolisthesisSpinal Stenosis Lumbar
Interventions
DEVICE

FIBERGRAFT BG Matrix

Subjects who meet the criteria for entrance into the study will undergo posterolateral fusion using FIBERGRAFT® BG Matrix in combination with autograft and bone marrow aspirate (BMA)

Trial Locations (9)

11021

Northwell Health Orthopaedic Institute, Great Neck

20817

Washington Spine & Scoliosis Institute at OrthoBethesda, Bethesda

22903

University of Virginia Orthopaedics, Charlottesville

33449

Palm Beach Neurosurgery, Wellington

42001

Orthopaedic Institute of Western Kentucky, Paducah

76132

Orthopedic and Neurologic Research Institute, Fort Worth

90806

Long Beach Medical Center, Long Beach

Memorial Orthopaedic Surgical Group, Long Beach

97401

KeiperSpine, PC, Eugene

All Listed Sponsors
lead

Prosidyan, Inc.

INDUSTRY

NCT03884283 - Prospective, Multi-center Study to Assess Posterolateral Fusion Using FIBERGRAFT | Biotech Hunter | Biotech Hunter